210 related articles for article (PubMed ID: 16269423)
1. Anti-inflammatory effects of leflunomide in combination with methotrexate on co-culture of T lymphocytes and synovial macrophages from rheumatoid arthritis patients.
Cutolo M; Capellino S; Montagna P; Sulli A; Seriolo B; Villaggio B
Ann Rheum Dis; 2006 Jun; 65(6):728-35. PubMed ID: 16269423
[TBL] [Abstract][Full Text] [Related]
2. Sex hormones modulate the effects of Leflunomide on cytokine production by cultures of differentiated monocyte/macrophages and synovial macrophages from rheumatoid arthritis patients.
Cutolo M; Montagna P; Brizzolara R; Sulli A; Seriolo B; Villaggio B; Triolo P; Clerico P; Soldano S
J Autoimmun; 2009; 32(3-4):254-60. PubMed ID: 19324522
[TBL] [Abstract][Full Text] [Related]
3. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
Pierer M; Brentano F; Rethage J; Wagner U; Hantzschel H; Gay RE; Gay S; Kyburz D
Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140
[TBL] [Abstract][Full Text] [Related]
4. CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production.
Cutolo M; Soldano S; Montagna P; Sulli A; Seriolo B; Villaggio B; Triolo P; Clerico P; Felli L; Brizzolara R
Arthritis Res Ther; 2009; 11(6):R176. PubMed ID: 19930661
[TBL] [Abstract][Full Text] [Related]
5. Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate.
Kane D; Gogarty M; O'leary J; Silva I; Bermingham N; Bresnihan B; Fitzgerald O
Arthritis Rheum; 2004 Oct; 50(10):3286-95. PubMed ID: 15476228
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis.
Cutolo M; Sulli A; Ghiorzo P; Pizzorni C; Craviotto C; Villaggio B
Ann Rheum Dis; 2003 Apr; 62(4):297-302. PubMed ID: 12634225
[TBL] [Abstract][Full Text] [Related]
7. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.
Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA
Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898
[TBL] [Abstract][Full Text] [Related]
8. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.
Varani K; Massara A; Vincenzi F; Tosi A; Padovan M; Trotta F; Borea PA
Arthritis Rheum; 2009 Oct; 60(10):2880-91. PubMed ID: 19790066
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis.
Bai S; Liu H; Chen KH; Eksarko P; Perlman H; Moore TL; Pope RM
Arthritis Rheum; 2004 Dec; 50(12):3844-55. PubMed ID: 15593196
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
Narváez J; Díaz-Torné C; Ruiz JM; Hernández MV; Torrente-Segarra V; Ros S; Rodriguez de la Serna A; Díaz-López C; Sanmartí R; Nolla JM
Semin Arthritis Rheum; 2011 Dec; 41(3):401-5. PubMed ID: 21862107
[TBL] [Abstract][Full Text] [Related]
11. [Enhancement by FK506 of triptolide-induced inhibition of expression of COX-2 and iNOS in human rheumatoid arthritis synovial fibroblasts].
Yao HP; Shao XT; Sun WJ; Shao CS; Zhang LH
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):277-82. PubMed ID: 12621554
[TBL] [Abstract][Full Text] [Related]
12. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
Kremer J; Genovese M; Cannon GW; Caldwell J; Cush J; Furst DE; Luggen M; Keystone E; Bathon J; Kavanaugh A; Ruderman E; Coleman P; Curtis D; Kopp E; Kantor S; Weisman M; Waltuck J; Lindsley HB; Markenson J; Crawford B; Fernando I; Simpson K; Strand V
J Rheumatol; 2004 Aug; 31(8):1521-31. PubMed ID: 15290730
[TBL] [Abstract][Full Text] [Related]
13. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of concurrent administration of cilostazol and methotrexate in rheumatoid arthritis: pharmacologic and clinical significance.
Kim HY; Lee SW; Park SY; Baek SH; Lee CW; Hong KW; Kim CD
Life Sci; 2012 Sep; 91(7-8):250-7. PubMed ID: 22820172
[TBL] [Abstract][Full Text] [Related]
15. Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels.
af Klint E; Grundtman C; Engström M; Catrina AI; Makrygiannakis D; Klareskog L; Andersson U; Ulfgren AK
Arthritis Rheum; 2005 Dec; 52(12):3880-9. PubMed ID: 16320336
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids.
Leech M; Metz C; Hall P; Hutchinson P; Gianis K; Smith M; Weedon H; Holdsworth SR; Bucala R; Morand EF
Arthritis Rheum; 1999 Aug; 42(8):1601-8. PubMed ID: 10446857
[TBL] [Abstract][Full Text] [Related]
17. Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers.
Kraan MC; Reece RJ; Barg EC; Smeets TJ; Farnell J; Rosenburg R; Veale DJ; Breedveld FC; Emery P; Tak PP
Arthritis Rheum; 2000 Aug; 43(8):1820-30. PubMed ID: 10943872
[TBL] [Abstract][Full Text] [Related]
18. Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis.
Brennan FM; Hayes AL; Ciesielski CJ; Green P; Foxwell BM; Feldmann M
Arthritis Rheum; 2002 Jan; 46(1):31-41. PubMed ID: 11822409
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate and cyclooxygenase metabolism in cultured human rheumatoid synoviocytes.
Vergne P; Liagre B; Bertin P; Cook-Moreau J; Treves R; Beneytout JL; Rigaud M
J Rheumatol; 1998 Mar; 25(3):433-40. PubMed ID: 9517759
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis.
Danning CL; Illei GG; Hitchon C; Greer MR; Boumpas DT; McInnes IB
Arthritis Rheum; 2000 Jun; 43(6):1244-56. PubMed ID: 10857783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
